A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host

Author(s):

Christian M. Harding, Mohamed A. Nasr, Nichollas E. Scott, Guillaume Goyette-Desjardins, Harald Nothaft, Anne E. Mayer, Sthefany M. Chavez, Jeremy P. Huynh, Rachel L. Kinsella, Christine M. Szymanski, Christina L. Stallings, Mariela Segura, Mario F. Feldman

Details:

Nature Communications, Volume 10, Issue 1, 2019-12-01, Article number 891

Article Link: Click here

Affiliations:

• University of Alberta
• Washington University School of Medicine in St. Louis
• University of Montreal
• University of Georgia
• The Peter Doherty Institute for Infection and Immunity
• Centre for Applied Synthetic Biology
• VaxNewMo LLC